TP53 and prostate cancer: We then generated stable HNF4α-knockdown infectants in two prostate cancer cell lines (LNCaP: AR-positive and wild-type p53-positive; PC-3: AR-negative and p53-deficient) by lentiviral shHNF4α infection (Fig. 3a).